THE EUROPEAN Commission has ordered American medicines information company IMS HEALTH (IMS) to abandon its refusal to allow rivals to copy its pharmaceutical sales and prescriptions data collection system in Germany.

In an unusual step, Brussels has used its powers as a competition authority to tell IMS to immediately licence the use of its 1860 brick structure method, over which it has copyright, "on commercial terms."

The Commission said that it had acted because competitors NDC Health, also of the USA and AzyX Geopharma ...

Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.